Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (2)

Subject

  • Drug Trafficking (83)
  • Synthetic drugs (24)
  • Fentanyl Awareness (20)
  • Fake Pills (14)
  • Fentanyl Free America (13)
  • One Pill Can Kill (7)
  • Extraditions (3)
  • Money Laundering (3)
  • Seizures (Drugs/Property) (3)
  • Gangs (2)
  • Guilty Plea (2)
  • OCDETF/Task Force (2)
  • Outreach/Drug Prevention (2)
  • Overdose (2)
  • Pharmaceuticals/Pharmacists/Physicians (2)
  • Prescription Drugs (2)
  • Take Back Day (2)
  • Campaigns (1)
  • Cartel (1)
  • Narcoterrorism (1)
  • Press Conferences (1)
  • Task Forces/Task Force Officers (1)
  • Terrorism (1)
  • Diversion Division (8)

Drug Name

  • Oxycodone (1)

Field Division

  • Atlanta (3)
  • Dallas (1)
  • El Paso (6)
  • Houston (5)
  • Los Angeles (2)
  • Louisville (1)
  • Miami (5)
  • New England (10)
  • New Jersey (3)
  • New Orleans (1)
  • New York (6)
  • Omaha (5)
  • Phoenix (2)
  • Rocky Mountain (2)
  • San Antonio (1)
  • San Francisco (7)
  • Seattle (7)
  • Sede (6)
  • St. Louis (8)
  • Washington, DC (4)
Clear All Results
View Archived Press Releases
8 Results - Showing 1 to 8
PRESS RELEASE

Texas Physician Sentenced to 12 Years in Prison for Operating a Houston-Area Pill Mill

Kingwood- A Texas physician was sentenced yesterday to 12.5 years in prison for operating her Kingwood medical clinic as an illegal pill mill that issued prescriptions for over 3 million opioid pills. According to court documents, Maryam Qayum, M.D., 68, of Montgomery County, Texas, owned, operated, and was the sole...
PRESS RELEASE

Cape May County Psychiatrist Admits to 17 Felonies in Illegal Prescription Case Linked to Sexual Conduct, Death, and Serious Bodily Injury

CAMDEN, N.J. – Special Agent in Charge of DEA’s New Jersey Field Division Towanda R. Thorne-James and U.S. Attorney for the District of New Jersey Robert Frazer announced a South Jersey psychiatrist admitted to issuing invalid prescriptions for Adderall, Vyvanse, and Xanax, and other drugs, often to his sexual partners...
PRESS RELEASE

DEA and United Against Fentanyl Announce National Partnership for Walk for Lives 2026

NEWARK, N.J. –The U.S. Drug Enforcement Administration and United Against Fentanyl (UAF) announced a national partnership in support of DEA’s Fentanyl Free America initiative. Walk for Lives 2026 is a coordinated series of more than 100 family-led community events across the United States on July 11, 2026. These events aim...
PRESS RELEASE

Camden County Pharmacist Charged with Illegally Dispensing Oxycodone

CAMDEN, N.J. – Special Agent in Charge of the Drug Enforcement Administration's New Jersey Field Division Towanda R. Thorne-James and U.S. Attorney for the District of New Jersey Robert Frazer announced a Camden County pharmacist was charged in an indictment with unlawfully distributing oxycodone, and his wife was separately charged...
PRESS RELEASE

Texas Doctor Charged with Illegally Distributing Millions of Opioid Pills

An indictment was unsealed today in the Southern District of Texas charging James Robles, 70, of Weslaco, Texas, with operating a cash-only clinic in Houston that he used to sell prescriptions for controlled substances. According to court documents, Robles, a medical doctor licensed to practice in Texas, conspired with others...
PRESS RELEASE

Laredo Pharmacist Pays Six Figures to Settle Controlled Substance Act Violations

HOUSTON – The owner of Martinez Pharmacy in Laredo has agreed to pay $750,000 to resolve allegations his pharmacy violated federal recordkeeping and dispensing requirements, announced Drug Enforcement Administration (DEA) Special Agent in Charge Miguel Madrigal of the San Antonio Division and U.S. Attorney Nicholas J. Ganjei. Antonio Martinez Jr...
PRESS RELEASE

Complaint Filed Against Houston Pharmacy and its Owners for Violations of the Controlled Substances Act

HOUSTON – A civil complaint has been filed seeking monetary penalties against a local pharmacy and its owners following an investigation revealing numerous fraudulent controlled substance prescriptions, announced Acting Special Agent in Charge William Kimbell of the Houston Division and U.S. Attorney Nicholas J. Ganjei. The complaint seeks civil monetary...
PRESS RELEASE

Private Shipping Company to Pay $400,000 to Settle Allegations of Transshipping Fentanyl Precursor Chemicals

SAN ANTONIO – IMC Pro International Inc. has agreed to pay $400,000 to the United States to resolve allegations it violated the Controlled Substances Act through transshipping fentanyl precursor chemicals. The United States alleged IMC Pro International Inc., a North Carolina-based shipping and logistics company, entered business agreements with several...
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster